Subscribe to RSS
DOI: 10.1055/a-1913-8223
LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous Cells
Funding This study was funded by the Fujian Natural Science Foundation (Youth Innovation) Project (No. 2020J05299) for Rui-Sheng Ke; Natural Science Foundation of Xiamen, China(No. 3502Z20209011) for Rui-Sheng Ke.
Abstract
The prognostic implications and physiological effect of LINC02875 are unknown in hepatocellular carcinoma (HCC). We sought to examine the prognostic value of LINC02875 in HCC and assessed its role in HCC cellular function. LINC02875 expression was evaluated by RT-qPCR in HCC specimens and cell lines. LINC02875 expression was subjected to assess the correlation with clinical parameters by Chi-squared test and overall survival by Kaplan – Meier curve and Cox regression analysis. The effects of LINC02875 on the biological characteristics of HCC cells were studied by MTS and Transwell assay. LINC02875 was high-expressed in HCC, and this was associated with unfavorable clinical features and poor prognosis of HCC, especially HBV-related HCC. Knockdown of LINC02875 inhibited the proliferation, migration, and invasion of HCC cells. miR-485–5p was a downstream microRNA of LINC02875. LINC02875 affects the prognosis of HCC patients, especially HBV-related ones. LINC02875 represents a suitable therapeutic target for HCC.
Publication History
Received: 27 April 2022
Accepted after revision: 19 July 2022
Article published online:
02 September 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 https://gco.iarc.fr/
- 2 Arnold M, Abnet CC, Neale RE. et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020; 159: 335-349
- 3 D’Souza S, Lau KC, Coffin CS. et al. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26: 5759-5783
- 4 Piñero F, Dirchwolf M, Pessôa MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells 2020; 9: 1370
- 5 Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 2019; 156: 477-491 e471
- 6 Casadei-Gardini A, Orsi G, Caputo F. et al. Developments in predictive biomarkers for hepatocellular carcinoma therapy. Expert Review of anticancer therapy 2020; 20: 63-74
- 7 Jathar S, Kumar V, Srivastava J. et al. Technological developments in lncRNA biology. Adv Exp Med Biol 2017; 1008: 283-323
- 8 Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell 2018; 172: 393-407
- 9 Chi Y, Wang D, Wang J. et al. Long non-coding RNA in the pathogenesis of cancers. Cells 2019; 8: 1015
- 10 Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res 2017; 77: 3965-3981
- 11 Lorenzi L, Avila Cobos F, Decock A. et al. Long noncoding RNA expression profiling in cancer: Challenges and opportunities. Genes Chromosomes Cancer 2019; 58: 191-199
- 12 Wang B, Yang S, Zhao W. Long non-coding RNA NRAD1 and LINC00152 are highly expressed and associated with prognosis in patients with hepatocellular carcinoma. OncoTargets Ther 2020; 13: 10409-10416
- 13 Xu X, Gu J, Ding X. et al. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression. Cell Death Dis 2019; 10: 752
- 14 Mou Y, Wang D, Xing R. et al. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Cancer Biomark 2018; 23: 95-106
- 15 Tang Z, Li C, Kang B. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucl Acids Res 2017; 45: W98-W102
- 16 Cheng M, Sun L, Huang K. et al. A signature of nine lncRNA methylated genes predicts survival in patients with glioma. Front Oncol 2021; 11: 646409
- 17 Ali T, Grote P. Beyond the RNA-dependent function of LncRNA genes. eLife 2020; 9: e60583
- 18 Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene 2017; 36: 5661-5667
- 19 Li D, Yang C, Yin C. et al. LncRNA, Important player in bone development and disease. Endocr Metab Immun Disord Drug Targets 2020; 20: 50-66
- 20 Liu SJ, Horlbeck MA, Cho SW. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017 355. aah7111
- 21 Akhade VS, Pal D, Kanduri C. Long Noncoding RNA: Genome organization and mechanism of action. Adv Exp Med Biol 2017; 1008: 47-74
- 22 Zhang S, Li C, Zhang Z. et al. Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer. J Cell Mol Med 2021; 25: 892-904
- 23 Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: An innate immune perspective. Biochim Biophys Acta Gene Regulat Mech 2020; 1863: 194419
- 24 Patil DP, Chen CK, Pickering BF. et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature 2016; 537: 369-373
- 25 Huang QR, Pan XB. Prognostic lncRNAs, miRNAs, and mRNAs Form a competing endogenous RNA network in colon cancer. Front Oncol 2019; 9: 712
- 26 Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci 2018; 19: 1310